Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 8/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13664124 | 0.80 | LMNA (0.56) | ALDH1A1LMNAERN1CYP1A2CYP2C19 | |
| SCHEMBL29414405 | 0.79 | ALDH1A1 (0.47) | ALDH1A1LMNAERN1CYP1A2CYP2C19 | |
| SCHEMBL4657547 | 0.76 | ALDH1A1 (0.49) | ALDH1A1LMNAERN1GAATRIM24 | |
| SCHEMBL13664493 | 0.76 | CA1 (0.52) | ALDH1A1ERN1TRIM24TYRTRIM33 | |
| SCHEMBL6699503 | 0.73 | ALDH1A1 (0.57) | ALDH1A1LMNAERN1CYP1A2CYP2C19 | |
| SCHEMBL27683962 | 0.72 | CA1 (0.57) | ALDH1A1LMNAERN1GAATRIM24 | |
| SCHEMBL11929032 | 0.72 | TSHR (0.47) | ALDH1A1LMNACYP1A2CYP2C19GAA | |
| SCHEMBL31563655 | 0.71 | ALDH1A1 (0.47) | ALDH1A1LMNAERN1GAATRIM24 | |
| SCHEMBL29084591 | 0.71 | ALDH1A1 (0.47) | ALDH1A1LMNAERN1GAATRIM24 | |
| SCHEMBL4796390 | 0.71 | CA1 (0.66) | ALDH1A1LMNAERN1GAATRIM24 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090270614-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME | NAGASE & CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270614-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME | BCAT1, BCAT2, AADAT | ALDH1A1 837/4885LMNA 4073/4885ERN1 1858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.